Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers. (2022)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/imm.13433
PubMed Identifier: 34775604
Publication URI: http://europepmc.org/abstract/MED/34775604
Type: Journal Article/Review
Volume: 165
Parent Publication: Immunology
Issue: 2
ISSN: 0019-2805